Airborne delivered two mirror support structures for the FYST and SOLAT telescopes, assembling assembling 26,300 components.

Key Insights Vertex Pharmaceuticals' estimated fair value is US$708 based on 2 Stage Free Cash Flow to Equity Vertex... The three-year partnership is another example of Vertex’s interest in ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...

KING OF PRUSSIA, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, has been named a Leader in ...

Vertex loses $12B in market cap The Boston drugmaker ... Related: MIT to start demolishing Kendall Square buildings in early 2025 Fall River bank hires former CFO of HarborOne Related: Fall ...

Vertex's CFTR modulators, led by Trikafta, helped the company generate more than $9.8 billion in product revenue last year, and in the latest quarter, product revenue rose 12% to $2.7 billion.

Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year's biotech winners, with the shares climbing 27% from January through a peak in November. The company, the global ...

Vertex Pharmaceuticals said Thursday that its closely watched drug, suzetrigine, reduced pain compared to baseline but did not outperform a placebo in a Phase 2 study, raising doubts about the ...

(RTTNews) - Shares of Vertex Pharmaceuticals Inc. (VRTX) are falling on Thursday morning after its Phase 2 Study results using placebo showed improved or rather similar results, compared to the ...